CIITA and neoplasm: The increased immunogenicity of the tumor generated by the CIITA-mediated MHC-II expression and the consequent adequate tumor antigen availability at the right time and at the right place affects dramatically the tumor microenvironment, moving the balance from a pro-tumor to an anti-tumor microenvironment.